Literature DB >> 29875236

The Murine Polyomavirus MicroRNA Locus Is Required To Promote Viruria during the Acute Phase of Infection.

James M Burke1, Clovis R Bass1, Rodney P Kincaid1, Emin T Ulug1, Christopher S Sullivan2.   

Abstract

Polyomaviruses (PyVs) can cause serious disease in immunosuppressed hosts. Several pathogenic PyVs encode microRNAs (miRNAs), small RNAs that regulate gene expression via RNA silencing. Despite recent advances in understanding the activities of PyV miRNAs, the biological functions of PyV miRNAs during in vivo infections are mostly unknown. The studies presented here used murine polyomavirus (MuPyV) as a model to assess the roles of the PyV miRNAs in a natural host. This analysis revealed that a MuPyV mutant that is unable to express miRNAs has enhanced viral DNA loads in select tissues at late times after infection. This is consistent with the PyV miRNAs functioning to reduce viral replication during the persistent phase of infection in a natural host. Additionally, the MuPyV miRNA locus promotes viruria during the acute phase of infection as evidenced by a defect in shedding during infection with the miRNA mutant virus. The viruria defect of the miRNA mutant virus could be rescued by infecting Rag2-/- mice. These findings implicate the miRNA locus as functioning in both the persistent and acute phases of infection and suggest a role for MuPyV miRNA in evading the adaptive immune response.IMPORTANCE MicroRNAs are expressed by diverse viruses, but for only a few is there any understanding of their in vivo function. PyVs can cause serious disease in immunocompromised hosts. Therefore, increased knowledge of how these viruses interact with the immune response is of clinical relevance. Here we show a novel activity for a viral miRNA locus in promoting virus shedding. This work indicates that in addition to any role for the PyV miRNA locus in long-term persistence, it also has biological activity during the acute phase. As this mutant phenotype is alleviated by infection of mice lacking an adaptive immune response, our work also connects the in vivo activity of the PyV miRNA locus to the immune response. Given that PyV-associated disease is associated with alterations in the immune response, our findings help to better understand how the balance between PyVs and the immune response becomes altered in pathogenic states.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  miRNA; polyomavirus; viral persistence; viral shedding; viruria

Mesh:

Substances:

Year:  2018        PMID: 29875236      PMCID: PMC6069185          DOI: 10.1128/JVI.02131-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  The epidemiology of mouse polyoma virus infection.

Authors:  W P ROWE
Journal:  Bacteriol Rev       Date:  1961-03

2.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

3.  A mouse polyomavirus-encoded microRNA targets the cellular apoptosis pathway through Smad2 inhibition.

Authors:  Chang Kyoo Sung; Hyungshin Yim; Erik Andrews; Thomas L Benjamin
Journal:  Virology       Date:  2014-08-20       Impact factor: 3.616

4.  The distribution and kinetics of polyomavirus in lungs of intranasally infected newborn mice.

Authors:  K Gottlieb; L P Villarreal
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

5.  SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells.

Authors:  Christopher S Sullivan; Adam T Grundhoff; Satvir Tevethia; James M Pipas; Don Ganem
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

6.  Reactivation of polyoma virus in kidneys of persistently infected mice during pregnancy.

Authors:  D J McCance; C A Mims
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

7.  Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression.

Authors:  Gil Ju Seo; Chun Jung Chen; Christopher S Sullivan
Journal:  Virology       Date:  2008-11-30       Impact factor: 3.616

Review 8.  Murine polyomavirus tumour specific transplantation antigens and viral persistence in relation to the immune response, and tumour development.

Authors:  Torbjörn Ramqvist; Tina Dalianis
Journal:  Semin Cancer Biol       Date:  2009-02-14       Impact factor: 15.707

Review 9.  Immunity to polyomavirus infection: the polyomavirus-mouse model.

Authors:  Phillip A Swanson; Aron E Lukacher; Eva Szomolanyi-Tsuda
Journal:  Semin Cancer Biol       Date:  2009-02-14       Impact factor: 15.707

10.  Cyclosporin A Promotes in vivo Myogenic Response in Collagen VI-Deficient Myopathic Mice.

Authors:  Francesca Gattazzo; Sibilla Molon; Valeria Morbidoni; Paola Braghetta; Bert Blaauw; Anna Urciuolo; Paolo Bonaldo
Journal:  Front Aging Neurosci       Date:  2014-09-15       Impact factor: 5.750

View more
  5 in total

1.  Control of Archetype BK Polyomavirus MicroRNA Expression.

Authors:  Wei Zou; Gau Shoua Vue; Benedetta Assetta; Heather Manza; Walter J Atwood; Michael J Imperiale
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

Review 2.  The Diverse Roles of microRNAs at the Host⁻Virus Interface.

Authors:  Annie Bernier; Selena M Sagan
Journal:  Viruses       Date:  2018-08-19       Impact factor: 5.048

Review 3.  Biology of Polyomavirus miRNA.

Authors:  Wei Zou; Michael J Imperiale
Journal:  Front Microbiol       Date:  2021-04-06       Impact factor: 5.640

Review 4.  Understanding polyomavirus CNS disease - a perspective from mouse models.

Authors:  Katelyn N Ayers; Sarah N Carey; Aron E Lukacher
Journal:  FEBS J       Date:  2021-07-02       Impact factor: 5.622

Review 5.  JCPyV VP1 Mutations in Progressive MultifocalLeukoencephalopathy: Altering Tropismor Mediating Immune Evasion?

Authors:  Matthew D Lauver; Aron E Lukacher
Journal:  Viruses       Date:  2020-10-12       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.